Charles Schwab
SILK

Charles Schwab’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Charles Schwab’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-318,638
Closed -$8.62M – 3627
2024
Q2 		$8.62M Buy
318,638
+10,171
+3% +$212K ﹤0.01% 2119
2024
Q1 		$5.65M Buy
308,467
+27,250
+10% +$432K ﹤0.01% 2238
2023
Q4 		$3.45M Sell
281,217
-16,927
-6% -$159K ﹤0.01% 2461
2023
Q3 		$4.47M Buy
298,144
+9,667
+3% +$201K ﹤0.01% 2308
2023
Q2 		$9.37M Buy
288,477
+6,145
+2% +$224K ﹤0.01% 1936
2023
Q1 		$11M Buy
282,332
+803
+0.3% +$39.3K ﹤0.01% 1819
2022
Q4 		$14.9M Buy
281,529
+27,629
+11% +$1.35M ﹤0.01% 1633
2022
Q3 		$11.4M Buy
253,900
+5,832
+2% +$251K ﹤0.01% 1761
2022
Q2 		$9.03M Sell
248,068
-4,890
-2% -$178K ﹤0.01% 1890
2022
Q1 		$10.4M Buy
252,958
+8,658
+4% +$305K ﹤0.01% 1931
2021
Q4 		$10.4M Buy
244,300
+4,639
+2% +$232K ﹤0.01% 1977
2021
Q3 		$13.2M Buy
239,661
+3,181
+1% +$166K ﹤0.01% 1849
2021
Q2 		$11.3M Buy
236,480
+17,660
+8% +$900K ﹤0.01% 1928
2021
Q1 		$11.1M Buy
218,820
+7,630
+4% +$424K ﹤0.01% 1903
2020
Q4 		$13.3M Buy
211,190
+5,186
+3% +$322K 0.01% 1681
2020
Q3 		$13.8M Buy
206,004
+78,637
+62% +$4.29M 0.01% 1464
2020
Q2 		$5.34M Buy
127,367
+66,281
+109% +$2.54M ﹤0.01% 1997
2020
Q1 		$1.92M Buy
61,086
+985
+2% +$39.4K ﹤0.01% 2289
2019
Q4 		$2.43M Buy
60,101
+10,006
+20% +$350K ﹤0.01% 2360
2019
Q3 		$1.63M Buy
50,095
+11,847
+31% +$472K ﹤0.01% 2452
2019
Q2 		$1.85M Buy
+38,248
New +$1.63M ﹤0.01% 2395

Other funds holding SILK

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Charles Schwab's SILK Position: Q3 2024 in Review

Charles Schwab sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 318,638 shares — an estimated $8.62M sold.

Charles Schwab first reported a position in SILK in Q2 2019 and held it in 21 quarters. The position peaked at $14.9M in Q4 2022. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

  • Charles Schwab reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Charles Schwab sold 318,638 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $8.62M.
  • Charles Schwab first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 21 quarters.
  • Charles Schwab's Silk Road Medical, Inc. Common Stock position peaked at $14.9M in Q4 2022.
  • 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on Charles Schwab's 13F filing for Q3 2024, filed 12 Nov 2024.